Literature DB >> 8504288

Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging.

C J Anderson1, P A Rocque, C J Weinheimer, M J Welch.   

Abstract

62Cu(T1/2 = 9.8 min) is a generator-produced positron-emitting radionuclide with a half-life amenable to blood-pool imaging with PET. Three bifunctional chelates [cyclic anhydride of diethylenetriaminepentaacetic acid (cDTPAA), 6-bromoacetamidobenzyl-1,4,8,11-tetraazacyclotetradecane-N,N ',N", N"'-tetraacetic acid (BAT), and p-carboxyethylphenylglyoxal-bis-(4N-methyl-thiosemicarbazone (CE-DTS)] were conjugated to HSA and labeled with 67Cu. The labeling efficiency of 67Cu-DTS-HSA was > 90%, whereas the labeling yields of 67Cu-DTPA-HSA and 67Cu-benzyl-TETA-HSA were less than 70%. Blood clearance and biodistribution of these three 67Cu-labeled conjugates were determined in rats. Of the three 67Cu-labeled bifunctional chelate-HSA conjugates, 67Cu-benzyl-TETA-HSA remained in the blood pool the longest, achieving stable blood levels at times longer than 24 h post-injection. The 67Cu radioactivity cleared the blood within 60 min post-injection of 67Cu-DTS-HSA, and within 10 min after administration of 67Cu-DTPA-HSA, indicating the dissociation of Cu2+ from these conjugates. Copper-labeled DTS-HSA achieved stable blood concentrations for at least 30 min post-injection and was therefore evaluated as a vascular imaging agent. DTS-HSA and benzyl-TETA-HSA were labeled with 62Cu and administered to a dog for blood-pool imaging using PET. Images were nearly identical to an image taken after administration of C15O. Because of the high labeling efficiency, DTS-HSA can be labeled with 62Cu without purification, making it more practical than 62Cu-benzyl-TETA-HSA as a blood-pool imaging agent.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504288     DOI: 10.1016/0969-8051(93)90077-8

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  6 in total

1.  An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution.

Authors:  Xiankai Sun; Raffaella Rossin; Jeffrey L Turner; Matthew L Becker; Maisie J Joralemon; Michael J Welch; Karen L Wooley
Journal:  Biomacromolecules       Date:  2005 Sep-Oct       Impact factor: 6.988

2.  In Vivo Labeling of Serum Albumin for PET.

Authors:  Gang Niu; Lixin Lang; Dale O Kiesewetter; Ying Ma; Zhongchan Sun; Ning Guo; Jinxia Guo; Chenxi Wu; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2014-05-19       Impact factor: 10.057

3.  Clinical Translation of an Albumin-Binding PET Radiotracer 68Ga-NEB.

Authors:  Jingjing Zhang; Lixin Lang; Zhaohui Zhu; Fang Li; Gang Niu; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2015-08-06       Impact factor: 10.057

4.  Synthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes.

Authors:  Grazia Papini; Simone Alidori; Jason S Lewis; David E Reichert; Maura Pellei; Giancarlo Gioia Lobbia; Gráinne B Biddlecombe; Carolyn J Anderson; Carlo Santini
Journal:  Dalton Trans       Date:  2008-11-04       Impact factor: 4.390

5.  Nanogels from metal-chelating crosslinkers as versatile platforms applied to copper-64 PET imaging of tumors and metastases.

Authors:  Jacques Lux; Alexander G White; Minnie Chan; Carolyn J Anderson; Adah Almutairi
Journal:  Theranostics       Date:  2015-01-01       Impact factor: 11.556

6.  Biodistribution of 68/67Ga-Radiolabeled Sphingolipid Nanoemulsions by PET and SPECT Imaging.

Authors:  Sandra Díez-Villares; Juan Pellico; Noemí Gómez-Lado; Santiago Grijalvo; Sandra Alijas; Ramon Eritja; Fernando Herranz; Pablo Aguiar; María de la Fuente
Journal:  Int J Nanomedicine       Date:  2021-08-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.